Isolated hypothalamic-pituitary langerhans' cell histiocytosis in female adult A case report

被引:19
作者
Tan, Huiwen [1 ,2 ]
Yu, Kai [1 ]
Yu, Yerong [1 ]
An, Zhengmei [1 ]
Li, Jianwei [1 ]
机构
[1] Sichuan Univ, Dept Endocrinol & Metab, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, Ctr Pituitary Adenoma & Related Dis, West China Hosp, Chengdu, Sichuan, Peoples R China
关键词
anterior pituitary hormone deficiency (APD); central diabetes insipidus; hypothalamic-hypophysial axial mass; langerhans' cell histiocytosis (LCH); multi-diciplinary treatment (MDT); CENTRAL DIABETES-INSIPIDUS; CLASSIFICATION; CYTOKINES; CHILDREN; TISSUES;
D O I
10.1097/MD.0000000000013853
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Langerhans cell histiocytosis (LCH) is characterized by clonal proliferation of immature dendritic cells, mainly affects children. LCH in adult sellar region is extremely rare. In literature, optimal treatments remain unclear and only a few cases of LCH were treated using surgery. Here, we present a rare case of isolated hypothalamic-pituitary LHC in female adult. We focused on elucidating the clinical manifestations and immunohistochemical features of LCH, and exploring the proper treatment in adults. Patient concerns: A 50-year-old woman was admitted to our hospital, presenting with polydipsia and polyuria for over 3 months. Diagnoses: Radiological studies revealed lesions (0.5 x 0.9 x 0.4 cm) on posterior pituitary and enlarged pituitary stalk, which was moderately enhanced on contrast magnetic resonance imaging (MRI) of sellar region. In biopsy, pathological examination of Langerhans cells were observed with positive S-100 protein and Ki-67 antigen markers, findings were sufficient to establish a diagnosis of central nervous system (CNS) LCH. Interventions: The patient with LCH restricted in the sellar region received both surgery and chemotherapy. Gamma knife radiosurgery was performed after diagnosed as central diabetes insipidus (CDI) induced by pituitary lesion. And tumorectomy was performed 5 years later. However, in the latest MRI in 2017, the nodular shadow became larger (about 1.4 cm), chemotherapy and further systemic therapy were given. Outcomes: At 12-month follow-up, no local reoccurrence was noticed. Lessons: For LCH, though difficult to be diagnosed and none defined standard therapeutic approach to adults, surgery should be considered if there are neurological symptoms or histological diagnosis. The present study showed that some manifestations can be meaningful when central nervous system (CNS) is involved. For complex diseases in the sellar region, multi-disciplinary team (MDT) model of diagnosis and treatment should be helpful for better clinical efficacy.
引用
收藏
页数:7
相关论文
共 34 条
  • [11] HISTIOCYTOSIS SYNDROMES CLASSIFICATION, DIAGNOSTIC FEATURES AND CURRENT CONCEPTS
    FAVARA, BE
    [J]. LEUKEMIA & LYMPHOMA, 1990, 2 (3-4) : 141 - +
  • [12] FAVARA BE, 1991, SEMIN ONCOL, V18, P3
  • [13] Histiocytoses: emerging neoplasia behind inflammation
    Haroche, Julien
    Cohen-Aubart, Fleur
    Rollins, Barret J.
    Donadieu, Jean
    Charlotte, Frederic
    Idbaih, Ahmed
    Vaglio, Augusto
    Abdel-Wahab, Omar
    Emile, Jean-Francois
    Amoura, Zahir
    [J]. LANCET ONCOLOGY, 2017, 18 (02) : E113 - E125
  • [14] Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years
    Haupt, Riccardo
    Minkov, Milen
    Astigarraga, Itziar
    Schaefer, Eva
    Nanduri, Vasanta
    Jubran, Rima
    Egeler, R. Maarten
    Janka, Gritta
    Micic, Dragan
    Rodriguez-Galindo, Carlos
    Van Gool, Stefaan
    Visser, Johannes
    Weitzman, Sheila
    Donadieu, Jean
    [J]. PEDIATRIC BLOOD & CANCER, 2013, 60 (02) : 175 - 184
  • [15] Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
    Hyman, David M.
    Puzanov, Igor
    Subbiah, Vivek
    Faris, Jason E.
    Chau, Ian
    Blay, Jean-Yves
    Wolf, Juergen
    Raje, Noopur S.
    Diamond, Eli L.
    Hollebecque, Antoine
    Gervais, Radj
    Elena Elez-Fernandez, Maria
    Italiano, Antoine
    Hofheinz, Ralf-Dieter
    Hidalgo, Manuel
    Chan, Emily
    Schuler, Martin
    Lasserre, Susan Frances
    Makrutzki, Martina
    Sirzen, Florin
    Veronese, Maria Luisa
    Tabernero, Josep
    Baselga, Jose
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08) : 726 - 736
  • [16] Ianosi ES, 2017, ROM J MORPHOL EMBRYO, V58, P1047
  • [17] Kumar Mahendra, 2015, Int J Hematol Oncol Stem Cell Res, V9, P193
  • [18] Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders
    Lau, Sean K.
    Chu, Peiguo G.
    Weiss, Lawrence M.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008, 32 (04) : 615 - 619
  • [19] 29 Year-Old Male with Seizure and Syncope Intracerebral Langerhans cell histiocytosis
    Le, Brian H.
    Truex, Raymond C.
    [J]. BRAIN PATHOLOGY, 2013, 23 (03) : 363 - 364
  • [20] A case of Langerhans' cell histiocytosis following Hodgkin's disease
    Li, Xin
    Deng, Qi
    Li, Yu-Ming
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (01) : 27 - 30